On Dec. 1, Jonathan Schein, global head of business development, Institutional Real Estate, Inc., hosted a webinar on life sciences properties, which have been attracting more attention from investors due to the industry’s growth in recent years and the property type’s positive fundamentals and “recession resilient” characteristics.
The following panelists shared their thoughts and insights of the sector: Tony Breault, senior real estate investment officer at Oregon State Treasury; Brian Combs, associate director at BLG Capital Advisors; Bill Hunter, senior vice president, life sciences at Thor Equities; Joseph Sitt, chairman and CEO of Thor Equities; and Bert van den Hoek, senior portfolio manager North America at Bouwinvest.
The panel addressed questions such as: What is the definition of life sciences? How does life sciences fit into an institutional investor’s portfolio? What investment property types exist within this sector? What types of opportunities
